[go: up one dir, main page]

PL2029740T3 - Zastosowanie polisacharydów do promowania aktywności enzymatycznej - Google Patents

Zastosowanie polisacharydów do promowania aktywności enzymatycznej

Info

Publication number
PL2029740T3
PL2029740T3 PL06760588T PL06760588T PL2029740T3 PL 2029740 T3 PL2029740 T3 PL 2029740T3 PL 06760588 T PL06760588 T PL 06760588T PL 06760588 T PL06760588 T PL 06760588T PL 2029740 T3 PL2029740 T3 PL 2029740T3
Authority
PL
Poland
Prior art keywords
polysaccharides
promotion
enzymatic activity
enzymatic
activity
Prior art date
Application number
PL06760588T
Other languages
English (en)
Inventor
Frank Riske
Michael Hayes
Gary Lazarus
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of PL2029740T3 publication Critical patent/PL2029740T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/718Starch or degraded starch, e.g. amylose, amylopectin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/08Ethers
    • C08B31/12Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01052Beta-N-acetylhexosaminidase (3.2.1.52)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0102Alpha-glucosidase (3.2.1.20)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01045Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL06760588T 2006-05-31 2006-05-31 Zastosowanie polisacharydów do promowania aktywności enzymatycznej PL2029740T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06760588A EP2029740B1 (en) 2006-05-31 2006-05-31 Use of polysaccharides for promotion of enzymatic activity
PCT/US2006/021092 WO2007139553A1 (en) 2006-05-31 2006-05-31 Use of polysaccharides for promotion of enzymatic activity

Publications (1)

Publication Number Publication Date
PL2029740T3 true PL2029740T3 (pl) 2012-11-30

Family

ID=37745607

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06760588T PL2029740T3 (pl) 2006-05-31 2006-05-31 Zastosowanie polisacharydów do promowania aktywności enzymatycznej

Country Status (7)

Country Link
US (2) US9175283B2 (pl)
EP (1) EP2029740B1 (pl)
JP (1) JP5094850B2 (pl)
ES (1) ES2386972T3 (pl)
PL (1) PL2029740T3 (pl)
PT (1) PT2029740E (pl)
WO (1) WO2007139553A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9175283B2 (en) 2006-05-31 2015-11-03 Genzyme Corporation Use polysaccharides for promotion of enzymatic activity
ES2773010T3 (es) * 2007-06-26 2020-07-09 Innonix Tech Incorporated Dispositivos para disminuir la trasmisión de patógenos humanos
JPWO2011037058A1 (ja) * 2009-09-22 2013-02-21 天野エンザイム株式会社 ラクターゼ剤
CN104807998B (zh) * 2015-05-12 2017-01-11 先思达(南京)生物科技有限公司 一种早期肝癌诊断试剂盒及其使用方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR504653A (fr) 1918-04-19 1920-07-12 Schneider & Cie Système de liaison entre l'affut et les chariots de chenilles pour matériels d'artillerie à flèche sur chaines sans fin
US3937821A (en) 1971-08-21 1976-02-10 Kyorin Seiyaku Kabushiki Kaisha Plasma substitute including artificial starch and method for the preparation thereof
DE2615844A1 (de) 1976-04-10 1977-10-20 Knoll Ag Fibrinogen spaltendes enzymsystem
JPS5470419A (en) 1977-11-16 1979-06-06 Wakamoto Pharma Co Ltd Stable urokinase powdery preparaton
US4473552A (en) 1981-03-16 1984-09-25 Jost Leonora I Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells
EP0116571B2 (en) 1982-08-30 1997-10-29 BAXTER INTERNATIONAL INC. (a Delaware corporation) Method for making gamma globulin-containing compositions
EP0150067A3 (en) 1984-01-23 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon
JPS60155136A (ja) 1984-01-23 1985-08-15 Takeda Chem Ind Ltd γ型インタ−フエロン組成物
EP0218112B1 (en) 1985-09-10 1992-12-09 Eisai Co., Ltd. Composition containing tissue plasminogen activator
US6007978A (en) 1988-05-18 1999-12-28 Cobe Laboratories, Inc. Method of freezing cells and cell-like materials
US6451600B1 (en) 1989-12-22 2002-09-17 Genzyme Corporation Enzymatically active recombinant glucocerebrosidase
US5723282A (en) 1991-07-08 1998-03-03 The American National Red Cross Method of preparing organs for vitrification
US6627275B1 (en) 1994-04-19 2003-09-30 Applied Elastomerics, Incorporated Tear resistant elastic crystal gels suitable for inflatable restraint cushions and other uses
US5616689A (en) 1994-07-13 1997-04-01 Collagen Corporation Method of controlling structure stability of collagen fibers produced form solutions or dispersions treated with sodium hydroxide for infectious agent deactivation
AU737077B2 (en) * 1997-03-12 2001-08-09 Novozymes A/S Storage-stable liquid formulation comprising a laccase
US6630137B1 (en) 1997-04-28 2003-10-07 Eli Lilly And Company Activated protein C formulations
PL195642B1 (pl) 1997-04-28 2007-10-31 Lilly Co Eli Sposób przetwarzania wodnego roztworu aktywowanego białka C
US6433161B1 (en) * 1997-04-29 2002-08-13 Hercules Incorporated Galactosylated hydroxyalkyl polysaccharides
ES2435141T3 (es) 1999-02-22 2013-12-18 University Of Connecticut Nuevas formulaciones de factor VIII libres de albúmina
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
CN1188111C (zh) 1999-10-29 2005-02-09 耐科塔医药公司 分散性得到改进的干粉组合物
IL150314A0 (en) 1999-12-30 2002-12-01 Maxygen Aps Improved lysosomal enzymes and lysosomal enzyme activators
CA2494241C (en) 2000-02-08 2011-06-14 Allergan, Inc. Botulinum toxin pharmaceutical compositions
US7780967B2 (en) 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
US20050169886A1 (en) * 2001-10-30 2005-08-04 Brody Richard S. Stabilization of biologically active proteins with mixtures of polysaccharides and amino acid based compounds
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
US6982080B2 (en) 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
WO2006108052A2 (en) * 2005-04-06 2006-10-12 Genzyme Corporation Peg and polysialic lysosomal enzyme conjugates via acid labile linkers for therapeutic targeting
AR053507A1 (es) 2006-05-31 2007-05-09 Genzyme Corp Uso de polisacaridos para la promocion de actividad enzimatica
US9175283B2 (en) 2006-05-31 2015-11-03 Genzyme Corporation Use polysaccharides for promotion of enzymatic activity

Also Published As

Publication number Publication date
US20090263371A1 (en) 2009-10-22
PT2029740E (pt) 2012-07-06
JP2009538619A (ja) 2009-11-12
US9175283B2 (en) 2015-11-03
EP2029740A1 (en) 2009-03-04
JP5094850B2 (ja) 2012-12-12
EP2029740B1 (en) 2012-06-20
WO2007139553A1 (en) 2007-12-06
US20160082090A1 (en) 2016-03-24
ES2386972T3 (es) 2012-09-10

Similar Documents

Publication Publication Date Title
IL232786A0 (en) Inhibitors of e1 enzyme activators
PT3225251T (pt) Modulação da atividade de proneurotrofinas
IL200212A0 (en) Inhibitors of akt activity
GB0619753D0 (en) Enzyme inhibitors
SI1848718T1 (sl) Inhibitorji E1 aktivacijskih enzimov
ZA200807862B (en) Azolopyrimidines as inhibitors of cannabinoid 1 activity
PT2097457T (pt) Derivados de polissacarídeos ácidos
IL194339A0 (en) Enzyme inhibitors
EP2114388A4 (en) INHIBITORS OF AKT'S ACTIVITY
IL197714A0 (en) 2-pyridinecarboxamide derivative having gk-activating activity
IL196480A0 (en) Improvement of arginase levels/activity
EP2134175A4 (en) HAMMER OF ACT ACTIVITY
IL198803A0 (en) Selective inhibitors of neurotensin degrading enzymes
PL2029740T3 (pl) Zastosowanie polisacharydów do promowania aktywności enzymatycznej
GB0608844D0 (en) Enzyme inhibitors
EP1923402A4 (en) PROCESS FOR DETERMINING ENZYME ACTIVITY
GB0617161D0 (en) Enzyme inhibitors
IL196789A0 (en) Imino-imidazo-pyridine derivatives having antithrombotic activity
GB2452842B (en) Method of increasing activity
GB2467284B (en) Sulfatase enzymes
AU2010301641B2 (en) Heparanase activity inhibitor
GB0612544D0 (en) Enzyme inhibitors
GB0624958D0 (en) Enzyme inhibitors
ZA200808237B (en) Enzyme inhibitors
GB0620884D0 (en) Enzyme inhibitors